Ethos Financial Group, LLC
- SEC CIK
- 0001954242
- Latest filing
- Aug 7, 2026
NWBO holding history
Northwest Biotherapeutics Inc in every 13F filed by Ethos Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NWBO overviewAll 13F holders of NWBOFull Q2 2026 holdings
- Shares (Q2 2026)
- 39,070
- Value
- $6.33K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 39,070 | $6.33K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 39,070 | $8.07K | <0.1% | +10,720+37.8% | Added | Holders |
| Q4 2025 | 28,350 | $6.49K | <0.1% | +3,000+11.8% | Added | Holders |
| Q3 2025 | 25,350 | $6.09K | <0.1% | −23,700−48.3% | Reduced | Holders |
| Q2 2025 | 49,050 | $12.6K | <0.1% | +25,350+107.0% | Added | Holders |
| Q1 2025 | 23,700 | $6.51K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 23,700 | $6.51K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 23,700 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 23,700 | $10.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 23,700 | $12.0K | <0.1% | +23,700 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −22,200−100.0% | Sold out | Holders |
| Q1 2023 | 22,200 | $13.9K | <0.1% | +22,200 | New | Holders |